AXA SA – Solvency and Financial Report 2022
Solvency
and Financial Condition Report
2022
|
|
|
|
SUMMARY |
7 |
|
A. BUSINESS AND PERFORMANCE |
11 |
|
A.1 Business |
12 |
|
/ General Information |
12 |
|
/ Information on the Company |
13 |
|
/ Major Shareholders and Related party transactions |
13 |
|
/ Business Overview |
14 |
|
/ Operating highlights |
14 |
|
A.2 Underwriting performance |
17 |
|
/ Aggregate underwriting performance |
17 |
|
/ Underwriting performance by geographical area |
17 |
|
/ Underwriting performance by product line |
18 |
|
A.3 Investment performance |
19 |
|
/ Net investment result |
19 |
|
/ Gains and losses directly recognized in Equity |
19 |
|
/ Investments in securitization |
20 |
|
A.4 Performance of other activities |
21 |
|
/ Net Income |
21 |
|
/ Leasing arrangements |
22 |
|
A.5 Any other information |
23 |
|
B. SYSTEM OF GOVERNANCE |
24 |
|
B.1 General information on the governance system |
25 |
|
/ Governance |
25 |
|
/ Compensation policy |
25 |
|
/ Directors' Fees |
26 |
|
/ Executive Officers Benefits |
26 |
|
B.2 Fit and proper requirements |
27 |
|
B.3 Risk management system including the own risk and solvency assessment |
28 |
|
/ Risk management system |
28 |
|
/ Own Risk and Solvency Assessment |
30 |
|
B.4 Internal control system |
31 |
|
B.5 Internal audit function |
31 |
|
B.6 Actuarial function |
31 |
|
B.7 Outsourcing |
32 |
|
B.8 Any other information |
33 |
|
C. RISK PROFILE |
34 |
|
/ Foreword |
35 |
|
/ Solvency II Capital Position |
35 |
|
C.1 Underwriting Risk |
37 |
|
/ Insurance Risk Exposure |
37 |
|
2 |
|
|
|
|
/ Risk Control and Risk Mitigation |
38 |
|
C.2 Market Risk |
39 |
|
/ Market Risk Exposure |
39 |
|
/ Risk Control and Risk Mitigation |
39 |
|
C.3 Credit Risk |
40 |
|
/ Credit Risk Exposure |
40 |
|
/ Risk Control and Risk Mitigation |
40 |
|
C.4 Liquidity Risk |
41 |
|
C.5 Operational Risk |
42 |
|
/ General Principles |
42 |
|
C.6 Other material Risks |
43 |
|
/ Strategic Risk |
43 |
|
/ Reputation Risk |
43 |
|
/ Emerging Risks |
43 |
|
C.7 Any other information |
43 |
|
D. VALUATION FOR SOLVENCY PURPOSES |
44 |
|
Basis for preparation |
45 |
|
D.1 - Assets |
47 |
|
/ Fair Value Measurement |
47 |
|
/ Intangible Assets |
49 |
|
/ Deferred taxes |
50 |
|
/ Property, Plant & Equipment held for own use |
50 |
|
/ Investments and loans |
51 |
|
/ Derivative instruments |
53 |
|
/ Reinsurance recoverables |
53 |
|
/ Leasing arrangements |
53 |
|
/ Assets held for index-linked and unit-linked |
54 |
|
/ Own shares |
54 |
|
/ Unrealized foreign exchange gains/losses |
54 |
|
/ Other assets |
54 |
|
D.2 - Technical provisions |
55 |
|
/ General Principles |
55 |
|
/ Best Estimate Liabilities |
56 |
|
/ Statement on the use of the volatility adjustment |
57 |
|
/ Statement on the use of the transitional measures for technical provisions |
58 |
|
/ Risk margin |
58 |
|
/ Reinsurance recoveries |
58 |
|
/ Material changes in assumptions in 2022 |
59 |
|
D.3 - Other liabilities |
60 |
|
/ Contingent liabilities |
60 |
|
3 |
|
|
||
|
/ Provisions other than technical provisions |
60 |
|
|
/ Pension benefit obligations |
61 |
|
|
/ Deferred taxes |
61 |
|
|
/ Financial liabilities |
61 |
|
|
/ Payables and deposits from reinsurers |
62 |
|
|
/ Other liabilities |
62 |
|
|
D.4 - Alternative methods for valuation |
63 |
|
|
D.5 - Any other material information |
63 |
|
|
E. CAPITAL MANAGEMENT |
64 |
|
|
E.1 Own funds |
......................................................................................................................................... |
65 |
|
/ Capital Management Objectives |
65 |
|
|
/ Information on the Capital Structure |
65 |
|
|
/ Change in capital resources in 2022 |
65 |
|
|
/ Tiering Analysis of capital |
66 |
|
|
/ Reconciliation to Local GAAP Shareholders' equity |
67 |
|
|
E.2 Solvency Capital Requirement and Minimum Capital Requirement |
68 |
|
|
/ General principles |
68 |
|
|
/ Solvency Capital Requirement (SCR) |
68 |
|
|
/ Minimum Capital Requirement (MCR) |
69 |
|
|
E.3 Use of the duration-based equity risk sub-module in the calculation of the Solvency Capital Requirement |
||
|
............................................................................................................................................................... |
70 |
|
|
E.4 Differences between the standard formula and any internal model used |
70 |
|
|
E.5 Non-compliance with the Minimum Capital Requirement and non-compliance with the |
||
|
Requirement |
70 |
|
|
E.6 Any other information |
70 |
|
|
APPENDICES |
71 |
|
|
Appendix I |
Annual Reporting Templates (QRTs) |
71 |
4
This report is the Solvency and Financial Condition Report (SFCR) of
Cautionary statement regarding forward looking statements
This Report may include statements with respect to future events, trends, plans, expectations or objectives and other forward-looking statements relating to the Group's future business, financial condition, results of operations, performance, and strategy. Forward-looking statements are not statements of historical fact and may contain the terms "may", "will", "should", "continue", "aims", "estimates", "projects", "believes", "intends", "expects", "plans", "seeks" or "anticipates" or words of similar meaning. Such statements are based on Management's current views and assumptions and, by nature, involve known and unknown risks and uncertainties; therefore, undue reliance should not be placed on them. Actual financial condition, results of operations, performance or events may differ materially from those expressed or implied in such forward- looking statements, due to a number of factors including, without limitation, general economic and political conditions and competitive situation; future financial market performance and conditions, including fluctuations in exchange and interest rates; frequency and severity of insured loss events, and increases in loss expenses; mortality and morbidity levels and trends; persistency levels; changes in laws, regulations and standards; the impact of acquisitions and disposal, including related integration issues, and reorganization measures; and general competitive factors, in each case on a local, regional, national and/or global basis. Many of these factors may be more likely to occur, or more pronounced, as a result of catastrophic events, including weather-related catastrophic events, pandemics, terrorist-related incidents or acts of war. Please refer to Part 5 "Risk factors and Risk Management" of
CERTAIN PRELIMINARY INFORMATION ABOUT THIS SFCR REPORT Transformation of
On
5
Attachments
Disclaimer


CerebrumX looks to transform connected vehicle landscape with unique offering
Life Reinsurance Market: Ready to Fly on High Growth Trends : Berkshire Hathaway, Lloyd's, Swiss Re
Advisor News
- How can more Americans achieve financial independence?
- Savers vs. spenders: How money management attitudes impact financial confidence
- Demonstrating the value of life insurance to Gen Z
- Poor money habits are a dealbreaker in a new relationship
- DC plan sponsors see opportunity in alternatives
More Advisor NewsAnnuity News
- The next growth phase in life/annuities depends on modernization
- CA judge certifies class action in teachers’ lawsuit over in-plan annuity fees
- Globe Life Inc. (NYSE: GL) Records 52-Week High Thursday Morning
- AM Best Managing Director Joins ‘Target Topics’ Podcast to Discuss State of Delegated Underwriting Authority Enterprises Market
- KBRA Assigns Rating to TruSpire Retirement Insurance Company
More Annuity NewsHealth/Employee Benefits News
- Findings from Yonsei University Advance Knowledge in Demography (Different Understandings of Scientific Research in the Use of De-identified Personal Sensitive Data: South Korea, in Comparative Perspectives): Science – Demography
- Data on Influenza Vaccines Discussed by Researchers at University of Lucerne (Keep Reminding Me To Get My Flu Shot): Immunization and Public Health – Influenza Vaccines
- Bobby Harrison: Rising insurance exchange costs bad for working poor
- New Managed Care Findings from Brown University Reported (Prior Authorization In Medicare Advantage: Beneficiary Exposure And Plan Disenrollment In 2021): Managed Care
- Findings on Managed Care Detailed by Researchers at Renal Research Institute (AI-Driven Interventions for Imminent Hospital Admissions in Patients with End-Stage Kidney Disease: A Medicare and EMR-Based Analysis): Managed Care
More Health/Employee Benefits NewsLife Insurance News
- Best’s Market Segment Report: AM Best Maintains Stable Outlook on South Korea’s Non-Life Insurance Market
- Horace Mann Strengthens Customer Relationships and Accelerates Long-Term Growth Through Transactions with Medical Mutual of Ohio
- Regulators: ‘No firm conclusions’ from first offshore reinsurance filings
- Allianz Life Study Finds Americans Struggle to Shift From Retirement Saving to Spending
- The next growth phase in life/annuities depends on modernization
More Life Insurance News